JAKARTA (Yosefardi) – Pharmaceutical company PT Darya-Varia Laboratoria Tbk (DVLA) suffered loss of Rp17.42 billion in first quarter of this year, compared to profit Rp43.79 billion in the same period of last year.
Net sales dropped 24% to Rp217.32 billion from previous Rp286.87 billion. Cost of sales also declined to 101 billion from earlier Rp107.88 billion.
Its assets totaled Rp1.18 trillion while liability amounted Rp286.06 billion. The company has cash and cash equivalent of Rp339.69 billion.